RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation.
Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, Dai J, Huang R, Peng X, Ye S, Lin Z, Huang S, Chong S, Lu L, Lu X.
Pan R, et al. Among authors: ye l, ye s.
iScience. 2022 Sep 23;25(10):105184. doi: 10.1016/j.isci.2022.105184. eCollection 2022 Oct 21.
iScience. 2022.
PMID: 36217544
Free PMC article.